The global renal disease market is expected to register a CAGR of 6.32% during the forecast period with a market value of USD 93,375.70 million in 2017. Renal diseases can be classified as chronic kidney disease (CKD) and end-stage renal disease (ESRD). Renal diseases may cause kidney failure. When CKD worsens, it eventually leads to ESRD. As per the National Institute of Diabetes and Digestive and Kidney Disease Report 2015, more than 6,61,000 Americans had kidney failure.
The rising prevalence of kidney diseases, diabetes, hypertension and rapid growth in the geriatric population have led to the growth of the global renal disease market in recent years. However, rising healthcare costs and stringent regulatory policies are likely to restrain market growth over the forecast period.
Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/3167
Segment analysis
The global renal disease market, by disease type, has been segmented into chronic kidney disease and end-stage renal diseases (ESRD). The chronic kidney disease segment accounted for a value of USD 60,228.68 million in 2017. The market, by treatment type, can be segmented into dialysis, medications and kidney transplantation. On the basis of end user, the global renal disease market is segmented into dialysis centers, hospitals & clinics, and research and academic institutes.
Regional Analysis
The Americas is expected to hold the largest share of the global renal disease market. This is owing to the increasing prevalence of renal diseases in the geriatric population and the availability of advanced healthcare facilities in the region. Europe showed a considerable amount of growth in the market due to high healthcare spending, raising awareness regarding renal diseases, extended recommendations for dialysis by the government and a growing elderly population. Asia-Pacific is estimated to be the fastest growing region in the global market due to the expansion of third-party pharmaceutical companies in China, India, and Singapore. Australia held a share of 11.8% in the Asia-Pacific renal disease market in 2017. Also, the Middle East and Africa region are expected to steadily grow owing to the rising prevalence of renal diseases in the region.
Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/renal-disease-market-3167
No comments:
Post a Comment